News

Caraco has executed a settlement agreement with MedImmune, stipulating the dismissal of the lawsuits filed in the US District Court for the District of Maryland. The case was

Repros Therapeutics, in the interest of patient safety, has voluntarily suspended dosing of all patients in its clinical trials of Proellex. The decision is based on available information

XenoPort has planned to file a new drug application (NDA) in Japan for XP13512 (ASP8825), as a potential treatment for moderate-to-severe primary restless legs syndrome (RLS), in the

Micromet has received Orphan Drug Designation from the European Medicines Agency (EMEA) for BiTE antibody blinatumomab (MT103), for acute lymphoblastic leukemia (ALL). Blinatumomab is a novel therapeutic antibody

ProAssurance has reported an operating income of $50.4m, or $1.52 per diluted share for the second quarter of 2009, an increase when compare to $46.6m for the second

The grant entails a collaborative effort between researchers at Micronics and the Seattle Children’s Research Institute (SCRI), in which a novel primer design method that enables detection of

In the second quarter of 2009, ZymoGenetics’ net loss improved to $27 million, or $0.39 per share, from $37.4 million, or $0.54 per share, for the second quarter

Cardinal Health has completed the aquisition of the assets of Biotech, an operator of Positron Emission Tomography (PET) cyclotrons and nuclear pharmacies in the Southwestern US. With the

The US FDA has approved Roche’s Avastin (bevacizumab) plus interferon alpha for people with metastatic renal cell carcinoma, the most common type of kidney cancer. The FDA approval